No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 20.2x · 10Y median 30.1x · 27th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 13
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T17:52:42.910Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T17:52:42.910Z. Latest historical point 2025-04-15. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T17:52:42.910Z. Latest historical point 2025-04-15. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T17:52:42.910Z. Latest historical point 2026-03-30.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T17:52:42.910Z. Latest historical point 2025-04-15. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T17:52:42.910Z. Latest historical point 2025-04-15. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for OneMedNet Corporation (ONMD) stock was $5.16 as of Oct 6, 2026, 1:41 PM EDT, up 0.88% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -50.2% · 3-year avg -64.4%/yr · 5-year avg -44.9%/yr
OneMedNet Corporation offers advanced solutions for clinical imaging. Their core product, iRWD, is an artificial intelligence-driven platform that securely anonymizes, searches for, and organizes imaging data.
Medical - Healthcare Information Services · Eden Prairie, MN
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
$-0.40
vs Estimate
N/A
Revenue
$292000.00
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1ONMD | $29.36M | $5.16 | +0.88% | -50.22% | -44.89% | N/A | N/A |
| 2CNTX | $29.51M | $0.32 | -4.55% | -69.24% | N/A | N/A | vs ONMD |
| 3QUCY | $29.71M | $1.30 | -3.33% | N/A | N/A | N/A | vs ONMD |
| 4GRDX | $29.81M | $4.18 | +9.14% | -11.92% | -83.84% | N/A | vs ONMD |
| 5TVGN | $28.86M | $6.93 | +5.00% | -80.26% | N/A | N/A | vs ONMD |
| 6MIRA | $29.86M | $0.71 | -3.39% | -45.36% | N/A | N/A | vs ONMD |
forward FY estimate
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$5.16
High
N/A
